Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Coronary Sinus | 4 | 2019 | 41 | 1.32 | Why? |
| Magnetic Resonance Imaging, Cine | 4 | 2020 | 669 | 1.28 | Why? |
| Vascular Calcification | 2 | 2021 | 396 | 1.28 | Why? |
| Angina Pectoris | 3 | 2019 | 114 | 1.09 | Why? |
| Myocarditis | 8 | 2021 | 2731 | 1.06 | Why? |
| Mitral Valve Prolapse | 1 | 2019 | 24 | 0.80 | Why? |
| Ventricular Fibrillation | 1 | 2019 | 126 | 0.73 | Why? |
| Multimodal Imaging | 2 | 2020 | 534 | 0.72 | Why? |
| Myocardial Contraction | 1 | 2019 | 123 | 0.70 | Why? |
| Tachycardia, Ventricular | 2 | 2018 | 251 | 0.69 | Why? |
| Iodine | 1 | 2018 | 116 | 0.66 | Why? |
| Image Enhancement | 1 | 2018 | 177 | 0.65 | Why? |
| Ventricular Function, Left | 3 | 2020 | 1555 | 0.61 | Why? |
| Pulmonary Artery | 1 | 2020 | 803 | 0.52 | Why? |
| Imaging, Three-Dimensional | 1 | 2019 | 680 | 0.52 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2020 | 453 | 0.52 | Why? |
| Defibrillators, Implantable | 1 | 2019 | 624 | 0.48 | Why? |
| Stroke Volume | 2 | 2019 | 2153 | 0.47 | Why? |
| Computed Tomography Angiography | 2 | 2021 | 2153 | 0.45 | Why? |
| Magnetic Resonance Imaging | 7 | 2019 | 6551 | 0.42 | Why? |
| Ventricular Dysfunction, Left | 1 | 2019 | 993 | 0.42 | Why? |
| Aorta, Thoracic | 2 | 2021 | 271 | 0.37 | Why? |
| Coronary Circulation | 3 | 2019 | 188 | 0.36 | Why? |
| Myocardium | 2 | 2021 | 2323 | 0.34 | Why? |
| Tomography, X-Ray Computed | 8 | 2021 | 25144 | 0.31 | Why? |
| Cardiac Surgical Procedures | 1 | 2019 | 1931 | 0.30 | Why? |
| Genetic Therapy | 2 | 2020 | 409 | 0.28 | Why? |
| Aortic Valve | 2 | 2021 | 664 | 0.26 | Why? |
| Italy | 13 | 2021 | 38444 | 0.26 | Why? |
| Ultrasonography, Interventional | 2 | 2018 | 560 | 0.25 | Why? |
| Predictive Value of Tests | 5 | 2021 | 9537 | 0.24 | Why? |
| Prostatic Neoplasms | 3 | 2019 | 1637 | 0.23 | Why? |
| Pancreatic Neoplasms | 2 | 2019 | 609 | 0.22 | Why? |
| Wiskott-Aldrich Syndrome | 1 | 2020 | 41 | 0.22 | Why? |
| Cardiac Catheterization | 2 | 2019 | 882 | 0.22 | Why? |
| Coronary Angiography | 3 | 2021 | 2275 | 0.21 | Why? |
| Radiography, Thoracic | 3 | 2021 | 5486 | 0.19 | Why? |
| Carbohydrate Metabolism | 1 | 2019 | 44 | 0.19 | Why? |
| Prostate | 2 | 2019 | 283 | 0.19 | Why? |
| Durapatite | 1 | 2018 | 18 | 0.19 | Why? |
| Neuromuscular Junction | 1 | 2018 | 18 | 0.18 | Why? |
| Intra-Abdominal Fat | 1 | 2021 | 227 | 0.18 | Why? |
| Magnetic Resonance Imaging, Interventional | 1 | 2018 | 38 | 0.18 | Why? |
| Magnetics | 1 | 2018 | 66 | 0.18 | Why? |
| Neoplasm Staging | 4 | 2019 | 1999 | 0.18 | Why? |
| Adiposity | 1 | 2021 | 329 | 0.18 | Why? |
| No-Reflow Phenomenon | 1 | 2017 | 14 | 0.18 | Why? |
| Female | 27 | 2021 | 380317 | 0.17 | Why? |
| Angina, Stable | 1 | 2017 | 45 | 0.17 | Why? |
| Male | 32 | 2021 | 367725 | 0.17 | Why? |
| Lung | 3 | 2021 | 31049 | 0.17 | Why? |
| Emergency Service, Hospital | 3 | 2020 | 14232 | 0.17 | Why? |
| Magnetite Nanoparticles | 1 | 2018 | 109 | 0.17 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.16 | Why? |
| Carcinogenesis | 1 | 2019 | 236 | 0.16 | Why? |
| Image-Guided Biopsy | 1 | 2018 | 185 | 0.16 | Why? |
| Coronary Vessels | 2 | 2021 | 914 | 0.16 | Why? |
| Pericardium | 2 | 2021 | 228 | 0.16 | Why? |
| Muscular Dystrophy, Duchenne | 1 | 2018 | 129 | 0.16 | Why? |
| Aortic Diseases | 1 | 2021 | 362 | 0.16 | Why? |
| Aged | 22 | 2021 | 215776 | 0.15 | Why? |
| Chemoradiotherapy | 1 | 2018 | 362 | 0.15 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.15 | Why? |
| Recovery of Function | 3 | 2021 | 2461 | 0.15 | Why? |
| Coronary Artery Disease | 4 | 2021 | 2570 | 0.14 | Why? |
| Syndrome | 1 | 2020 | 1310 | 0.14 | Why? |
| Myocardial Perfusion Imaging | 1 | 2017 | 218 | 0.14 | Why? |
| Body Surface Potential Mapping | 1 | 2014 | 20 | 0.14 | Why? |
| Electrocardiography | 2 | 2019 | 3957 | 0.14 | Why? |
| Glucose | 1 | 2019 | 573 | 0.14 | Why? |
| Protein Engineering | 1 | 2018 | 536 | 0.14 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2018 | 365 | 0.13 | Why? |
| Rectal Neoplasms | 1 | 2018 | 278 | 0.13 | Why? |
| Heart Valve Prosthesis | 1 | 2019 | 533 | 0.13 | Why? |
| Multidetector Computed Tomography | 1 | 2017 | 307 | 0.13 | Why? |
| Stents | 2 | 2018 | 916 | 0.13 | Why? |
| Humans | 41 | 2021 | 930598 | 0.13 | Why? |
| Hospital Units | 1 | 2020 | 1017 | 0.13 | Why? |
| Exercise Test | 1 | 2019 | 911 | 0.12 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.12 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.12 | Why? |
| Hemodynamics | 2 | 2018 | 1562 | 0.12 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2019 | 665 | 0.12 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.12 | Why? |
| Esophageal Neoplasms | 1 | 2017 | 357 | 0.11 | Why? |
| Equipment Design | 2 | 2019 | 3095 | 0.11 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.11 | Why? |
| Stomach Neoplasms | 1 | 2017 | 477 | 0.11 | Why? |
| Aortic Valve Stenosis | 1 | 2019 | 741 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 839 | 0.10 | Why? |
| Heart | 1 | 2020 | 1791 | 0.10 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.10 | Why? |
| Acute Coronary Syndrome | 2 | 2021 | 2107 | 0.10 | Why? |
| Acute Disease | 2 | 2021 | 6029 | 0.10 | Why? |
| Catheter Ablation | 1 | 2014 | 438 | 0.10 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.09 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.09 | Why? |
| Arrhythmias, Cardiac | 2 | 2020 | 2510 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.08 | Why? |
| Saphenous Vein | 1 | 2007 | 67 | 0.08 | Why? |
| Prostate-Specific Antigen | 2 | 2018 | 213 | 0.08 | Why? |
| Neoplasm Grading | 2 | 2018 | 400 | 0.08 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.08 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.07 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
| Contrast Media | 3 | 2018 | 1011 | 0.07 | Why? |
| Percutaneous Coronary Intervention | 2 | 2017 | 3646 | 0.06 | Why? |
| Mice, Inbred C57BL | 3 | 2019 | 5542 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2021 | 243684 | 0.06 | Why? |
| Clozapine | 1 | 2007 | 218 | 0.06 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Wiskott-Aldrich Syndrome Protein | 1 | 2020 | 37 | 0.06 | Why? |
| Mice, Transgenic | 2 | 2019 | 2739 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Coronary Artery Bypass | 1 | 2007 | 629 | 0.05 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2017 | 3051 | 0.05 | Why? |
| Adult | 7 | 2020 | 244371 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.05 | Why? |
| Web Browser | 1 | 2020 | 84 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Balloon Valvuloplasty | 1 | 2019 | 49 | 0.05 | Why? |
| Fluoroscopy | 1 | 2019 | 140 | 0.05 | Why? |
| Hospital Information Systems | 1 | 2020 | 115 | 0.05 | Why? |
| Thermogravimetry | 1 | 2018 | 14 | 0.05 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 100 | 0.05 | Why? |
| Utrophin | 1 | 2018 | 2 | 0.05 | Why? |
| Mice, Inbred mdx | 1 | 2018 | 5 | 0.05 | Why? |
| Digital Rectal Examination | 1 | 2018 | 19 | 0.05 | Why? |
| Homeodomain Proteins | 1 | 2019 | 93 | 0.05 | Why? |
| Dextrans | 1 | 2018 | 35 | 0.05 | Why? |
| Mice | 4 | 2019 | 21357 | 0.05 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Biopsy | 2 | 2018 | 2811 | 0.05 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 112 | 0.04 | Why? |
| Zinc Fingers | 1 | 2018 | 109 | 0.04 | Why? |
| Antipsychotic Agents | 1 | 2007 | 887 | 0.04 | Why? |
| Trans-Activators | 1 | 2019 | 170 | 0.04 | Why? |
| Treatment Outcome | 7 | 2019 | 51732 | 0.04 | Why? |
| X-Ray Diffraction | 1 | 2018 | 249 | 0.04 | Why? |
| Precancerous Conditions | 1 | 2018 | 108 | 0.04 | Why? |
| Phagocytes | 1 | 2018 | 180 | 0.04 | Why? |
| Methotrexate | 1 | 2021 | 471 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Tertiary Care Centers | 3 | 2020 | 8248 | 0.04 | Why? |
| Prosthesis Design | 1 | 2019 | 594 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2019 | 310 | 0.04 | Why? |
| Aorta | 1 | 2019 | 355 | 0.04 | Why? |
| Tissue Distribution | 1 | 2018 | 483 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.04 | Why? |
| Catheterization, Peripheral | 1 | 2019 | 249 | 0.04 | Why? |
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 279 | 0.04 | Why? |
| Calcium | 1 | 2021 | 708 | 0.04 | Why? |
| Preliminary Data | 1 | 2017 | 457 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Antibodies, Antiphospholipid | 1 | 2020 | 519 | 0.04 | Why? |
| Neoadjuvant Therapy | 1 | 2018 | 554 | 0.04 | Why? |
| Pancreas | 1 | 2018 | 398 | 0.04 | Why? |
| Organometallic Compounds | 1 | 2017 | 206 | 0.04 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.03 | Why? |
| Drainage | 1 | 2018 | 414 | 0.03 | Why? |
| Neurodegenerative Diseases | 1 | 2020 | 469 | 0.03 | Why? |
| Probability | 1 | 2018 | 923 | 0.03 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| HeLa Cells | 1 | 2018 | 1303 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Regression Analysis | 1 | 2021 | 2484 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Compassionate Use Trials | 1 | 2017 | 632 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2018 | 881 | 0.03 | Why? |
| Radiography | 1 | 2020 | 1576 | 0.03 | Why? |
| Iron | 1 | 2018 | 619 | 0.03 | Why? |
| Surgery, Computer-Assisted | 1 | 2014 | 183 | 0.03 | Why? |
| Nanotechnology | 1 | 2018 | 821 | 0.03 | Why? |
| Malnutrition | 1 | 2021 | 932 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2017 | 663 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.03 | Why? |
| Young Adult | 2 | 2019 | 93724 | 0.03 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Animals | 4 | 2019 | 78931 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Rheology | 1 | 2007 | 70 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Gadolinium DTPA | 1 | 2007 | 45 | 0.02 | Why? |
| Infant | 2 | 2020 | 30274 | 0.02 | Why? |
| Pulsatile Flow | 1 | 2007 | 123 | 0.02 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.02 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Stroke | 1 | 2021 | 8839 | 0.01 | Why? |
| Schizophrenia | 1 | 2007 | 1018 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
Esposito's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(229)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(235)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_